Alpha-1 antitrypsin deficiency associated (AATD) is a leading genetic cause of liver disease, yet it remains largely underdiagnosed and poorly understood. This interactive symposium features a multispecialty expert panel to provide insights into the pathophysiologic and genetic underpinnings, best practices in diagnosing, and navigating the management of AATD liver disease.
Supported by: An educational grant from Takeda Development Center Americas, Inc.